FDA approves an oral treatment for postpartum depression called zuranolone

The FDA on Friday announced its approval of an oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill. Roxana Saberi has more on how the pill can help women deal with one of the most common medical complications after pregnancy.